Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Carbonic anhydrase (CA) is a crucial enzyme for CO2 metabolism and pH homeostasis.
• Sulfonamides are known inhibitors of carbonic anhydrase, with a history of therapeutic applications.
• Specific carbonic anhydrase isoenzymes are implicated in the progression of cancers like brain and breast cancer.

Purpose of the Study:

• To review the extensive research on carbonic anhydrase.
• To highlight the therapeutic potential of carbonic anhydrase inhibitors.
• To address existing challenges in the discovery of novel CA inhibitors.

Main Methods:

• Literature review of carbonic anhydrase research.
• Analysis of therapeutic applications of CA inhibitors.
• Discussion of recent advancements and challenges in inhibitor discovery.

Main Results:

• Carbonic anhydrase plays a fundamental role in physiological processes.
• CA inhibitors have demonstrated efficacy in treating glaucoma and as diuretics.
• Targeted CA inhibitors are being developed for cancer therapy.

Conclusions:

• The broad research scope of carbonic anhydrase underscores its physiological importance.
• Targeted inhibition of specific CA isoenzymes offers promising therapeutic avenues, particularly in oncology.
• Further research is needed to overcome challenges in developing selective and effective CA inhibitors.